Surgeons who observe persistent fluid buildup after disconnecting epileptic and healthy brain areas should think twice before installing low-pressure nonprogrammable drainage shunts, according to a study co-authored by Rutgers pediatric and epilepsy neurosurgeon Yasunori Nagahama that found chronic headaches could result from these procedures.

The study in Operative Neurosurgery followed 70 children who underwent a connection-severing surgery known as functional hemispherotomy for intractable epilepsy between 1994 and 2018 to see if inserting permanent drainage shunts after surgery increased the brain’s tendency to shift across the skull after surgery.

Epilepsy afflicts about 3.4 million Americans, according to the Centers for Disease Control. Various surgeries can help the 1 million people whose seizures can’t be controlled by medication. Hemispherotomy often eliminates seizures in juvenile patients whose epilepsy affects one side (or hemisphere) of the brain by removing some tissue and severing connections between the healthy and overactive hemispheres. However, tissue removal reduces local pressure, causing the remaining brain tissue to shift toward the low-pressure zone. This shift can cause persistent headaches and other problems.

The study is the first to examine whether shunts, which allow excess cerebrospinal fluid to drain into the abdominal cavity, increase brain shift and, if so, whether certain types of shunts increase it more than others.

The study’s initial measurements of average midline brain shift were comparable in shunted and nonshunted patients, but final measurements were 16.3 millimeters in shunted kids and 9.7 millimeters in nonshunted kids. Further investigation by Nagahama and colleagues from the University of California, Los Angeles suggests insufficient pressure in some shunt opening valves created the increased brain shift.

Patients whose shunts required above-average pressure to open their valves and drain fluid fared comparably to nonshunted patients. Patients whose shunts had below-average valve opening pressure experienced an average brain shift of 18.7 millimeters. Researchers also found that nonprogrammable shunt valves were associated with elevated brain shift — 18.9 millimeters — while programmable valves weren’t.

“The finding that shunts as a whole increase midline brain shift is interesting but not actionable,” said Nagahama, the director of pediatric epilepsy surgery at Rutgers University’s Robert Wood Johnson Medical School. You have to install shunts when there’s chronic cerebrospinal fluid buildup.”

“The second finding — that some types of shunts were associated with increased brain shift while others were not — is certainly an area for further research and possibly something for surgeons to consider in choosing shunts for this patient population,” the assistant professor added.

Nagahama said the study findings make intuitive sense. The brain naturally shifts from high-pressure areas to low-pressure areas until the pressure equalizes. Removing fluid further reduces pressure in an area that’s already missing brain tissue and thus increases brain shift. Shunts with valves that only open at higher pressures reduce the pressure differentials and reduce brain shift.

“Efforts to reduce brain shift should naturally focus on reducing pressure differences across the brain cavity,” said Nagahama, who specializes in epilepsy surgeries, including functional hemispherotomy.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is melted ice?

Explore More

Fat cells help repair damaged nerves

Damage to the body’s peripheral nerves can cause pain and movement disorders. Researchers at the Leipzig University have recently investigated how damaged nerves can regenerate better. They found that fat

Some children with cerebral palsy scoliosis may not need pelvic fixation, study shows

A new Michigan Medicine study finds that some children with cerebral palsy and scoliosis do not require pelvic fixation when undergoing growing rod treatment, potentially avoiding several complications. Using data

Breakthrough in glioblastoma treatment with the help of a virus

In a recently published manuscript, Howard Colman, MD, PhD, Jon M. Huntsman Presidential Professor of Neuro-Oncology and co-leader of the Neurologic Cancers Disease Center and the Experimental Therapeutics CCSG program